Tumori primitivi multipli del polmone. Profilo clinico e biologico in pazienti affetti da neoplasie polmonari multiple. Analisi di elementi clinici e marcatori biologici come possibili fattori di differenziazione dei tumori polmonari multipli

Background: MPLC represents a diagnostic challenge. Topic of the discussion is how to distinguish these patients as a metastatic or a multifocal disease. While in case of the different histology there are less doubt on the opposite in case of same histology is mandatory to investigate on other clinical features to rule out this question. Matherials and Methods: A retrospective review identified all patients treated surgically for a presumed diagnosis of SPLC. Pre-operative staging was obtained with Total CT scan and fluoro-deoxy positron emission tomography and mediastinoscopy. Patients with nodes interest or extra-thoracic location were excluded from this study. Epidermal growth factor receptor (EGFR) expression with complete immunohistochemical analisis was evaluated. Survival was estimated using Kaplan-Meyer method, and clinical features were estimated using a long-rank test or Cox proportional hazards model for categorical and continuous variable, respectively. Results: According to American College Chest Physician, 18 patients underwent to surgical resection for a diagnosis of MPLC. Of these, 8 patients had 3 or more nodules while 10 patients had less than 3 nodules. Pathologic examination demonstrated that 13/18(70%) of patients with multiple histological types was Adenocarcinoma, 2/18(10%) Squamous carcinoma, 2/18(10%) large cell carcinoma and 1/18(5%) Adenosquamosu carcinoma. Expression of EGFR has been evaluated in all nodules: in 7 patients of 18 (38%) the percentage of expression of each nodule resulted different. Conclusions: MPLC represent a multifocal disease where interactions of clinical informations with biological studies reinforce the diagnosis. EGFR could contribute to differentiate the nodules. However, further researches are necessary to validate this hypothesis.

Monte Carlo simulation of the WENDI-2 neutron dosimeter

Il presente lavoro di tesi, sviluppato nell’arco di sei mesi presso l’Institut Supérieur Industriel de Bruxelles (ISIB) in collaborazione con Ion Beam Application Group (IBA, Louvain la Neuve), ha come principale soggetto lo studio della risposta del rem meter WENDI-2 commercializzato da Thermo Scientific. Lo studio si è basato principalmente sull’uso del codice Monte Carlo MCNPX 2.5.0, simulando la risposta del detector sia in caso di campi di radiazione neutronica monoenergetici sia in corrispondenza di spettri neutronici continui. La prima fase è stata dedicata alla modellizzazione MCNPX del rem counter, consentendo così la valutazione della sua funzione risposta. Questa è stata ricostruita interpolando 93 punti, ciascuno calcolato in corrispondenza di un singolo valore di energia di una sorgente puntiforme, compreso tra 1 meV e 5 GeV. In tal caso è stata rilevata un’ottima corrispondenza tra i risultati ottenuti e quelli riportati nella letteratura scientifica esistente. In una seconda fase, al fine di ottenere informazioni sulla risposta di WENDI II in corrispondenza di campi complessi di radiazione, simulazioni MCNPX sono state realizzate riproducendo un ambiente di lavoro esistente presso la sede IBA di Louvain la Neuve: la risposta del detector è stata valutata in corrispondenza di 9 diverse posizioni all’interno di un bunker contenente un ciclotrone PET (18 MeV H-), implicando la rilevazione di campi di radiazione neutronica continui ed estesi dalle energie termiche fino a 18 MeV. I risultati ottenuti sono stati infine comparati con i valori di dose ambiente equivalente calcolata nelle stesse condizioni di irraggiamento.

Influenza del sistema immunogenetico KIR nell'alloreattività Natural Killer nel trapianto di rene

Kidney transplantation is the best treatment option for the restoration of excretory and endocrine kidney function in patients with end-stage renal disease. The success of the transplant is linked to the genetic compatibility between donor and recipient, and upon progress in surgery and immunosuppressive therapy. Numerous studies have established the importance of innate immunity in transplantation tolerance, in particular natural killer (NK) cells represent a population of cells involved in defense against infectious agents and tumor cells. NK cells express on their surface the Killer-cell Immunoglobulin-like Receptors (KIR) which, by recognizing and binding to MHC class I antigens, prevent the killing of autologous cells. In solid organ transplantation context, and in particular the kidney, recent studies show some correlation between the incompatibility KIR / HLA and outcome of transplantation so as to represent an interesting perspective, especially as regards setting of immunosuppressive therapy. The purpose of this study was therefore to assess whether the incompatibility between recipient KIR receptors and HLA class I ligands of the donor could be a useful predictor in order to improve the survival of the transplanted kidney and also to select patients who might benefit of a reduced regimen. One hundred and thirteen renal transplant patients from 1999 to 2005 were enrolled. Genomic DNA was extracted for each of them and their donors and genotyping of HLA A, B, C and 14 KIR genes was carried out. Data analysis was conducted on two case-control studies: one aimed at assessing the outcome of acute rejection and the other to assess the long term transplant outcome. The results showed that two genes, KIR2DS1 and KIR3DS1, are associated with the development of acute rejection (p = 0.02 and p = 0.05, respectively). The presence of the KIR2DS3 gene is associated with a better performance of serum creatinine and glomerular filtration rate (MDRD) over time (4 and 5 years after transplantation, p <0.05), while in the presence of ligand, the serum creatinine and MDRD trend seems to get worse in the long term. The analysis performed on the population, according to whether there was deterioration of renal function or not in the long term, showed that the absence of the KIR2DL1 gene is strongly associated with an increase of 20% of the creatinine value at 5 years, with a relative risk to having a greater creatinine level than the median 5-year equal to 2.7 95% (95% CI: 1.7788 - 2.6631). Finally, the presence of a kidney resulting negative for HLA-A3 / A11, compared to a positive result, in patients with KIR3DL2, showed a relative risk of having a serum creatinine above the median at 5 years after transplantation of 0.6609 (95% CI: 0.4529 -0.9643), suggesting a protective effect given to the absence of this ligand.

Progettazione robusta di un motore Stirling

Descrizione dell'applicazione di tecniche di progettazione robusta, robust design, ad un motore Stirling per generazione di corrente elettrica. La progettazione robusta è una tecnica che permette lo sviluppo di prodotti cercando di minimizzare gli effetti negativi dovuti a variazioni inaspettate nei parametri di progetto, interessante, quindi, perchè in ambito industriale accade spesso che i valori nominali dei parametri per cui si progetta un dispositivo od una macchina siano diversi da quelli che si presentano nel suo reale funzionamento.

Eterogeneità delle proprietà fisico – chimiche della proteina prionica patologica e variabilità fenotipica ceppo specifica nella malattia di Creutzfeldt – Jakob

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are neurodegenerative disorders that affect humans and mammals. Creutzfeldt-Jakob disease (CJD), the most common TSE in humans, can be sporadic (sCJD), genetic (gCJD), or acquired by infection. All TSEs are characterised by the accumulation of PrPSc, a misfolded form of the cellular protein PrPC. PrPSc is insoluble in detergents, partially resistant to proteolysis and shows a highly enriched β-sheet secondary structure. Six clinico-pathological phenotypes of sCJD have been characterized which correlate at the molecular level with two types (1 or 2) of PrPSc with distinctive physicochemical properties and the genotype at the polymorphic (methionine or valine) codon 129 of the prion protein gene. According to the protein-only hypothesis, which postulates that prions are composed exclusively of PrPSc, the strains of prions that are largely responsible for the wide spectrum of TSE phenotypes are enciphered in PrPSc conformation. In support to this view, studies mainly conducted in experimental scrapie, have shown that several prion strains can be identified based on distinguishing PrPSc biochemical properties. To further contribute to the understanding of the molecular basis of strains and to develop more sensitive strain typing assays in humans we have analyzed PrPSc biochemical properties in two experimental setting. In the first we compared the size of the core after protease digestion and the glycoform pattern of PrPSc before and after transmission of human prions to non human primates or bank voles, whereas in the second we analyzed the conformational stability of PrPSc associated with sCJD, vCJD or fCJD using guanidine hydrochloride (GdnHCl) as denaturant. Combining the results of the two studies, we were able to distinguish five human strains for at least one biochemical property. The present data extend our knowledge about the extent of strain variation and its relationship with PrPSc properties in human TSEs.

Il Nilotinib nella terapia di prima linea della leucemia mieloide cronica

Background: Nilotinib is a potent and selective BCR-ABL inhibitor. The phase 3 ENESTnd trial demonstrated superior efficacy nilotinib vs imatinib, with higher and faster molecular responses. After 24 months, the rates of progression to accelerated-blastic phase (ABP) were 0.7% and 1.1% with nilotinib 300mg and 400mg BID, respectively, significantly lower compared to imatinib (4.2%). Nilotinib has been approved for the frontline treatment of Ph+ CML. With imatinib 400mg (IRIS trial), the rate of any event and of progression to ABP were higher during the first 3 years. Consequently, a confirmation of the durability of responses to nilotinib beyond 3 years is extremely important. Aims: To evaluate the response and the outcome of patients treated for 3 years with nilotinib 400mg BID as frontline therapy. Methods: A multicentre phase 2 trial was conducted by the GIMEMA CML WP (ClinicalTrials.gov.NCT00481052). Minimum 36-month follow-up data for all patients will be presented. Definitions: Major Molecular Response (MMR): BCR-ABL/ABL ratio <0,1%IS; Complete Molecular Response (CMR): undetectable transcript levels with ≥10,000 ABL transcripts; failures: according to the revised ELN recommendations; events: failures and treatment discontinuation for any reason. All the analysis has been made according to the intention-to-treat principle. Results: 73 patients enrolled: median age 51 years; 45% low, 41% intermediate and 14% high Sokal risk. The cumulative incidence of CCgR at 12 months was 100%. CCgR at each milestone: 78%, 96%, 96%, 95%, 92% at 3, 6, 12, 18 and 24 months, respectively. The overall estimated probability of MMR was 97%, while the rates of MMR at 3, 6, 12, 18 and 24 months were 52%, 66%, 85%, 81% and 82%, respectively. The overall estimated probability of CMR was 79%, while the rates of CMR at 12 and 24 months were 12% and 27%, respectively. No patient achieving a MMR progressed to AP. Only one patient progressed at 6 months to ABP and subsequently died (high Sokal risk, T315I mutation). Adverse events were mostly grade 1 or 2 and manageable with appropriate dose adaptations. During the first 12 months, the mean daily dose was 600-800mg in 74% of patients. The nilotinib last daily dose was as follows: 800mg in 46 (63%) patients, 600mg in 3 (4%) patients and 400mg in 18 (25%), 6 permanent discontinuations. Detail of discontinuation: 1 patient progressed to ABP; 3 patients had recurrent episodes of amylase and/or lipase increase (no pancreatitis); 1 patient had atrial fibrillation (unrelated to study drug) and 1 patient died after 32 months of mental deterioration and starvation (unrelated to study drug). Two patients are currently on imatinib second-line and 2 on dasatinib third-line. With a median follow-up of 39 months, the estimated probability of overall survival, progression-free survival and failure-free survival was 97%, the estimated probability of event-free survival was 91%. Conclusions: The rate of failures was very low during the first 3 years. Responses remain stable. The high rates of responses achieved during the first 12 months are being translated into optimal outcome for most of patients.

Soluzioni classiche e viscose dell'equazione di curvatura di Gauss-Levi

Nella presente tesi ci siamo occupati dell'equazione di curvatura di Gauss-Levi, prima introducendo le nozioni necessarie alla sua definizione, poi cercandone soluzioni viscose. A tale scopo abbiamo introdotto in generale la nozione di soluzione viscosa per operatori ellittici degeneri, dimostrandone l'esistenza grazie al Principio del Confronto e al Metodo di Perron. Abbiamo infine riportato alcuni risultati che collegano le soluzioni viscose dell'equazione di curvatura, a quelle classiche.

Evidenza del coinvolgimento di geni nell'insorgenza delle schisi labio-palatine

The CL/P are the most common and easily recognizable craniofacial malformations with a complex etiology that requires the involvement of genetic and environmental components. The analysis of the genetic component shows more than 14 loci and genes involved in the onset of the disease. I’ve selected and investigated some of the possible candidate genes for CL/P. MYH14 gene, that maps on chromosome 19, on the OFC3 locus, and shows a strong homology with MYH9 gene. I’ve also investigated TP63 and MID1 genes, that are responsible respectively for EEC syndrome and Opitz syndrome, both of them presenting cleft. I’ve also decided to investigate JAG2 because TP63 product regulates the this gene, and both of them are component of the Notch signalling pathway. I’ve, also, studied the MKX and LMO4 genes. MKX is an important development regulator that is highly expressed in palatal mesenchyme, and map in the region responsible for Twirler mutation that cause cleft in mouse. LMO4 is necessary for neural tube development and cooperating with Grhl3, promotes cellular migration during morphogenetic events like “in utero” cleft healing. Low folate levels and high levels of homocysteine increase the risk of cleft, genes involved in their metabolism may be of interest in cleft occurrence. I’ve decided to investigate BHMT and CBS genes coding for enzymes involved in homocysteine metabolism. I’ve also investigated BHMT2 gene that maps close to BHMT and presents with him a 73% of homology. I’ve performed a linkage analysis using SNPs mapping in the genes and their boundaries, for each gene, for MKX and LMO4 I’ve also performed a sequencing analysis. My results for MID1 and CBS genes support the hypothesis of a possible role of these genes in cleft. I’ve found borderline association values for JAG2, MKX and LMO4 genes.

Ruolo delle specie reattive dell'ossigeno e di caveole/raft lipidici nella biosegnalazione in linee cellulari umane

Membrane lipid rafts are detergent-resistant microdomains containing glycosphingolipids, cholesterol and glycosylphosphatidylinositol-linked proteins; they seem to be actively involved in many cellular processes including signal transduction, apoptosis, cell adhesion and migration. Lipid rafts may represent important functional platforms where redox signals are produced and transmitted in response to various agonists or stimuli. In addition, a new concept is emerging that could be used to define the interactions or amplification of both redox signalling and lipid raft-associated signalling. This concept is characterized by redox-mediated feed forward amplification in lipid platforms. It is proposed that lipid rafts are formed in response to various stimuli; for instance, NAD(P)H oxidase (Nox) subunits are aggregated or recruited in these platforms, increasing Nox activity. Superoxide and hydrogen peroxide generation could induce various regulatory activities, such as the induction of glucose transport activity and proliferation in leukaemia cells. The aim of our study is to probe: i) the involvement of lipid rafts in the modulation of the glucose transporter Glut1 in human acute leukemia cells; ii) the involvement of plasma membrane caveolae/lipid rafts in VEGF-mediated redox signaling via Nox activation in human leukemic cells; iii) the role of p66shc, an adaptor protein, in VEGF signaling and ROS production in endothelial cells (ECs); iv) the role of Sindecan-2, a transmembrane heparan sulphate proteoglycan, in VEGF signaling and physiological response in ECs and v) the antioxidant and pro-apoptotic activities of simple dietary phenolic acids, i. e. caffeic, syringic and protocatechuic acids in leukemia cells, characterized by a very high ROS content. Our results suggest that the role played by NAD(P)H oxidase-derived ROS in the regulation of glucose uptake, proliferation and migration of leukaemia and endothelial cells could likely occur through the control of lipid raft-associated signalling.

Timing per l'inserimento in lista dei pazienti affetti da fibrosi cistica che necessitano di trapianto polmonare: casistica di un centro regionale di riferimento

Timing of waiting list entrance for patients with cystic fibrosis in need of pulmonary transplant: the experience of a regional referral centre Objective: Evaluation of parameters that can predict a rapid decay of general conditions of patients affected by Cystic Fibrosis (CF) with no specific criteria to be candidate to pulmonary transplant. Material and methods: Fifteen patients with CF who died for complications and 8 who underwent lung transplantation in the 2000-2010 decade, were enrolled. Clinical data 2 years before the event (body max index, FEV1%, number of EV antibiotic treatments per year, colonization with Methicillin-resistant Staphylococcus aureus (MRSA), pseudomonas aeruginosa mucosus, burkholderia cepacia, pulmonary allergic aspergilosis) were compared among the 2 groups. Results: Mean FEV1% was significantly higher and mean number of antibiotic treatment was lower in deceased than in the transplanted patients (p<0.002 and p<0.001 respectively). Although in patients who died there were no including criteria to enter the transplant list 2 years before the exitus, suggestive findings such as low BMI (17.3), high incidence of hepatic pathology (33.3%), diabetes (50%), and infections with MRSA infection (25%), Pseudomonas aeruginosa (83.3%) and burkholderia cepacia (8.3%) were found with no statistical difference with transplanted patients, suggesting those patients were at risk of severe prognosis. In patients who died, females were double than males. Conclusion: While evaluating patients with CF, negative prognostic factors such as the ones investigated in this study, should be considered to select individuals with high mortality risk who need stricter therapeutical approach and follow up. Inclusion of those patients in the transplant waiting list should be taken into account.

Nuovi processi catalitici per la sintesi di prodotti ad attività farmacologica

The transition metal-catalyzed allylic alkylation (Tsuji-Trost type reaction) is a powerful tool for C-C, C-N, and C-O bond formation, which has been widely applied to organic chemistry over the last decades. Typical substrates for this transformation are activated allylic compounds such as halides, esters, carbonates, carbamates, phosphates, and so on. However, use of these substrates is associated with the disadvantage of generating a stoichiometric amount of chemical waste. Furthermore, these starting materials have to be prepared in an extra step from the corresponding allylic alcohol. Thus, ideal substrates would be the allylic alcohols themselves, with water being the only byproduct in this case. However, the scarse propensity of the hydroxyl moiety to act as good leaving group has significantly limited their use so far. During the last decade significant efforts have been made in order to develop more atom-economical and environmentally-friendly allylic alkylation protocols by employing allylic alcohols directly. In this PhD dissertation two main projects addressing this topic are presented. “Project 1” deals with the development of new metal-catalyzed intramolecular Friedel-Crafts (FC) allylic alkylations of electron-rich (PAPER A), as well as challenging electron-poor arenes (PAPER B) with alcohols. In “Project 2”, gold(I)-catalyzed intramolecular and stereoselective allylic alkylation reactions are reported. In particular, a FC alkylation of indole-containing allylic alcohols is presented in PAPER C. While, an O-alkylation of aminol-containing allylic alcohols is reported in PAPER D. To the best of knowledge, these reports represent the first example of gold(I)-catalyzed stereoselective alkylations with alcohols.

Valutazione non distruttiva di muratura in laterizio: applicazione in laboratorio di tomografia sonica e prove dirette

Il patrimonio edilizio italiano è costituito in gran parte da costruzioni che utilizzano la muratura come struttura portante. Le conoscenze acquisite negli ultimi anni nel campo dell’ingegneria hanno reso evidente come le costruzioni in muratura siano state concepite, nel corso dei secoli, senza quegli accorgimenti che l’evoluzione delle tecniche moderne di analisi ha dimostrato essere necessari. Progettare un intervento edilizio su un edificio esistente, correlato anche alla valutazione di rischio sismico, e cercare di migliorare le prestazioni dello stesso edificio, richiede partire sempre dalla conoscenza delle caratteristiche statiche intrinseche che il materiale della muratura possiede. La conoscenza della patologia comporta l'indubbio vantaggio di mettere al corrente di cosa ci si può attendere nel futuro dal punto di vista strutturale, come ad esempio che il fenomeno non sarà eliminabile all'origine e che la fessura o lesione magari si riformerà sempre, a meno d’interventi statici rilevanti e di costi ingenti. Diventa quindi di fondamentale importanza eseguire uno studio approfondito dei fenomeni strutturali anomali di deterioramento, quali lesioni, fessurazioni e simili, legati spesso a fattori ambientali, attraverso specifiche indagini diagnostiche e di monitoraggio dello stato interno delle strutture, per definire le cause responsabili e il metodo più adeguato alla tutela dei beni storici [Mastrodicasa, 1993]. Il monitoraggio dei possibili parametri che influenzano tali processi può essere continuo nel tempo o per mezzo di metodologia discontinua che prevede l’utilizzo e la ripetizione di prove non distruttive. L’elevato costo di un eventuale processo continuo ha limitato significativamente la sua applicazione, riducendo lo studio all’analisi di pochi parametri derivanti dalle prove diagnostiche e spesso non del tutto adatti alla completa analisi della struttura. Il seguente lavoro di tesi è sviluppato all’interno del progetto SmooHS (Smart Monitoring of Historic Structures) nell’ambito del 7° Programma Quadro della Commissione Europea che si pone come obiettivo lo sviluppo di strumenti di monitoraggio innovativi ‘intelligenti’ e poco invasivi e modelli di degrado e la loro sperimentazione sul campo per verificarne l’effettiva efficacia attraverso il confronto con risultati di prove non distruttive. La normativa correlata a questo studio, “Norme Tecniche per le Costruzioni’ (D.M. 14/01/2008), evidenzia come ‘La conoscenza della costruzione storica in muratura è un presupposto fondamentale sia ai fini di un’attendibile valutazione della sicurezza sismica attuale sia per la scelta di un efficace intervento di miglioramento…. Si ha pertanto la necessità di affinare tecniche di analisi e interpretazione dei manufatti storici mediante fasi conoscitive dal diverso grado di attendibilità, anche in relazione al loro impatto. La conoscenza può, infatti, essere conseguita con diversi livelli di approfondimento, in funzione dell’accuratezza delle operazioni di rilievo, delle ricerche storiche, e delle indagini sperimentali. Tali operazioni saranno funzione degli obiettivi preposti e andranno a interessare tutto o in parte l’edificio, secondo la tipologia dell’intervento previsto’. L’utilizzo di ‘Tecniche diagnostiche non distruttive di tipo indiretto, quali prove soniche e ultrasoniche’ è preferibile poiché molto promettenti e hanno il pregio di poter essere utilizzate in modo diffuso con un relativo impatto sulla costruzione e costi relativamente contenuti. La non identificazione di una procedura univoca di prove non distruttive per ciascuna tipologia edilizia rende necessario uno studio di fattibilità di diverse tecniche per valutarne l’effettiva efficacia in base al risultato atteso. L’obiettivo di questo lavoro di tesi è stato lo studio sperimentale di valutazione dell’efficacia di alcune tecniche soniche in trasmissione, tomografia e prove soniche dirette, nel monitoraggio di provini precedentemente realizzati ad hoc nei laboratori LISG (Laboratorio di Ingegneria Strutturale e Geotecnica) del DICAM dell’Università di Bologna caratterizzati da presenze di discontinuità (vacui o inclusioni di polistirolo) o materiali differenti in determinate posizioni di geometria e localizzazione nota e diverse tessiture murarie (muratura di laterizio tradizionale, muratura a sacco, inclusioni lapidee). Il capitolo 1 presenta una descrizione generale delle murature, le cause principali di deterioramento e conseguenti dissesti. Presenta inoltre una finestra sulle prove diagnostiche. Nel capitolo 2 sono riportati alcuni esempi di applicazioni di tomografia e prove soniche e sviluppi di ricerca su strutture storiche lignee e murarie eseguite recentemente. Nel capitolo 3 sono presentati i provini oggetto di studio, la loro geometria, i difetti, le sezioni. Il capitolo 4 descrive i principi fisici delle prove soniche e grandezze caratteristiche e presenta la procedura di acquisizione e relative strumentazioni. I capitoli 5 e 6 riguardano lo studio sperimentale vero e proprio ottenuto attraverso l’utilizzo di tomografia sonica e prove dirette, con descrizione delle stazioni di prova, visualizzazione dei dati in tabelle per una semplice interpretazione, loro elaborazione e susseguente analisi approfondita, con valutazione dei risultati ottenuti e debite conclusioni. Il capitolo 7 presenta un confronto delle analisi comuni a entrambe le tipologie di prove soniche, visualizzazioni di istogrammi di paragone e considerazioni deducibili.